🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
250 Servings
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

500 mg
📊 Market median: 500.0mg (159 products)
Median 500.0mg This product: 500mg

Other Ingredients

Cellulose Vegetable Stearin Cellulose Gum Magnesium Stearate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one (1) tablet, two (2) times daily. For extra skin support during stressful times, take two (2) tablets, three (3) times daily, or as directed by a health care professional.

⚠️ Warnings & Precautions

KEEP OUT OF THE REACH OF CHILDREN.

DO NOT USE IF SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

🧪 Formulation Notes

Contains No: Gluten, sugar, salt, yeast, corn, wheat, lactose, citrus, milk, egg, fish products, artificial coloring, flavoring, or preservatives.

Additional Information

Store in a cool, dry place. Do not refrigerate. Please recycle.

500 MG

FITNESS

GMP Compliant Manufacturing

Lysine is required for collagen synthesis (which benefits the skin). It also plays a role in immune function, and may be important to bone health.†

MADE IN THE USA

Our L-Lysine is a pure crystalline, free form amino acid.

Supports Immune Function & Collagen Synthesis/Skin Health†

Product Details

UPC / SKU 8 12720 01568 0
DSLD Entry Date 2011-11-25
Product Type Amino acid/Protein
Form Tablet or Pill
DSLD ID 1758
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →